Mode
Text Size
Log in / Sign up

Pilot study evaluates molecular POCT for Streptococcus pyogenes in childrenFast Strep Test Might Stop Unnecessary Antibiotics for Children

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that this pilot study suggests POCT could reduce antibiotic use but is not approved for clinical use.

This is a pilot research study conducted in a West London paediatric emergency department. The scope was to evaluate a molecular point-of-care test (POCT) on a second research throat swab for Streptococcus pyogenes in children under 16 years, while clinical management was based on conventional culture swabs.

The authors synthesized findings from 49 participants. Swab positivity in symptomatic children was 12.8% (6/47). Antibiotic use was frequent, with 38/49 (77.6%) participants receiving antibiotics; of those recommended to receive antibiotics, 29/38 (76.3%) had a negative POCT. Time to reporting of positive throat swab culture results was a mean of 3.67 days (range 3-5 days), while POCT results were available within minutes.

Key limitations noted by the authors include the low prevalence of streptococcal infection during the study period (May 2023-June 2025), that the molecular POCT was not approved for use in the host NHS Trust, and that clinical management was unaffected by the research swab result.

The authors suggest that POCT could avoid or stop antibiotic use in over three-quarters of children in the ED if suspicion of S. pyogenes is the main driver for prescribing. However, this is a pilot study with a small sample size, and the findings should be interpreted with caution.

Why waiting causes problems

Strep throat is a common infection in kids. It causes pain and fever that keeps families up at night. Doctors often prescribe antibiotics just in case.

This happens even when the germ isn't there. Standard tests need a lab to grow bacteria. They take days to give an answer.

During that time, parents worry. Kids suffer. Doctors worry about missing a real infection.

How science is changing

Old tests rely on growing germs in a dish. This is slow and requires sending samples away. A new method looks at genetic material directly.

It works like a quick scan instead of a long wait. This technology is called a molecular test. It finds the strep bacteria right there in the room.

A simple way to scan

Think of the old way like mailing a letter. You send it, wait for a reply, and hope it arrives. The new test is like a phone call.

It connects instantly. It finds the strep bacteria right there in the room. This means doctors can decide faster.

Where the research happened

Researchers tested this in a London children's hospital. They looked at kids under 16 with sore throats. Most kids got antibiotics anyway.

But the fast test changed the picture. They compared the new test to the old lab test. They tracked how long each took.

About three out of four kids got antibiotics. The fast test said most of them did not have strep. This means many kids took medicine they did not need.

This doesn’t mean this treatment is available yet.

Of those children recommended to receive antibiotics, over three-quarters had a negative result. This shows the test could stop unnecessary treatment.

Expert views on speed

Experts say this is a promising start. It shows how data can change habits. Doctors might stop guessing when they have fast answers.

Antibiotic resistance is a growing global concern. Using fewer drugs helps keep them working longer. This test supports that goal.

What families can do

You cannot buy this test at home. It is for hospital use only. Talk to your doctor about sore throats.

Do not demand antibiotics for viral infections. Ask if a rapid test is an option. Your doctor knows the best path for your child.

Why caution is needed

The study was small. It happened in one place. The infection rate was low during the study period.

We need more data from other hospitals. The test was not approved for use in that specific trust. This limits how we can apply the results now.

Next steps for science

More trials will happen before approval. Scientists want to prove it works everywhere. Real-world use takes time to get right.

Regulators must check the safety and accuracy. Hospitals need to train staff on the new tools. This process ensures quality care for everyone.

More trials will happen before approval. Scientists want to prove it works everywhere. Real-world use takes time to get right.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background An upsurge in Streptococcus pyogenes infections 2022-2023 highlighted potential benefits of point-of-care tests (POCT) to support clinical pathways, prevent outbreaks, and optimise antibiotic use. Objectives We conducted a pilot research study in a west London paediatric emergency department (ED) to determine whether a molecular POCT had potential to alter management in children who were also having a conventional throat swab taken for culture. Methods Children <16 years presenting to ED who had a throat swab requested by a clinician were invited to have a second swab taken for research purposes only. Clinical management was unaffected by the research swab result, which was processed using a molecular POCT that was not approved for use in the host NHS Trust. Results Prevalence of streptococcal infection was low during the study (May 2023-June 2025); swab positivity in symptomatic children was 12.8% (6/47). Overall, 38/49 (77.6%) participants who had throat swabs received antibiotics. Of those children recommended to receive antibiotics, 29/38 (76.3%) had a negative POCT. Mean time to reporting of positive throat swab culture results was 3.67 days (range 3-5 days) leading to occasional delay in treatment, although POCT identified positive results within minutes. Conclusion Antibiotic use was frequent and could be avoided or stopped by use of a rule out POCT in over three-quarters of children in the ED, if suspicion of S. pyogenes is the main driver for prescribing. POCT were easy to process and produced immediate results compared with culture, in theory enabling timely decision-making and avoiding treatment delay.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.